Palavra-chave: AUTOLOGOUS STEM CELL TRANSPLANTATION

HODGKINS LYMPHOMA MULTIPLE MYELOMA 462 PATIENTS CHEMOTHERAPY DATA META-ANALYSIS RETROSPECTIVE STUDY NON-HODGKIN´S LYMPHOMAS THALIDOMIDE RELAPSE ADVANCED MULTIPLE MYELOMA REFRACTORY LYMPHOMAS CD34+ INTERNATIONAL MYELOMA WORKING GROUP NON HODGKIN LYMPHOMA B CELL LYMPHOMA PROGRESSION-FREE SURVIVAL HIGH DOSE SEQUENTIAL EBMT RITUXIMABE HODGKIN LYMPHOMA HIGH DOSE CYCLOPHOSPHAMIDE CHEMO-RADIOTHERAPY SALVAGE APPROACHES RANDOMIZED STUDY THALIDOMIDE DEXAMETHASONE HODGKIN S LYMPHOMA DEXAMETHASONE NON-HODGKIN´S LYMPHOMA HIGH DOSE CHEMOTHERAPY